Skip to main content
. 2023 Dec 12;29(12):3050–3058. doi: 10.1038/s41591-023-02600-4

Fig. 5. Cost-effectiveness acceptability curves.

Fig. 5

These curves show the probability of a strategy being the most cost-effective for a range of WTP values of US$100–$2,000 per HALY. USD, US dollar ($); yrly, yearly; yrs, years. *All positive women treated after assessment of eligibility for ablative treatment. Some strategies had a small probability of being cost-effective but are not visible on the graph and are as follows: primary VIA screening (high sensitivity) every 5 years for ages 30–50 had <4% probability of being the most cost-effective approach for WTP US$290–$570/HALY saved. Primary VIA screening (high sensitivity) every 3 years for ages 30–50 had <5% chance of being the most cost-effective approach for WTP US$480–$1,095/HALY saved. Primary HPV with HPV16/18 triage every 5 years for ages 30–50 had <0.1% chance of being the most cost-effective approach for WTP US$410–$440/HALY saved.